| |
Before treatment (n = 87)
|
After treatment (n = 87)
|
P
|
|---|
|
Body weight (kg)
|
71.2 ± 13.9
|
70.6 ± 13.8
|
0.03
|
|
Systolic BP (mmHg)
|
131.2 ± 11.7
|
128.3 ± 16.1
|
0.06
|
|
Diastolic BP (mmHg)
|
79.0 ± 11.2
|
75.1 ± 11.2
|
0.01
|
|
Hemoglobin (g/dL)
|
12.1 ± 2.0
|
11.9 ± 1.9
|
0.04
|
|
Phosphorus (mg/dL)
|
3.6 ± 0.6
|
3.7 ± 0.7
|
0.07
|
|
Uric acid (mg/dL)
|
7.1 ± 1.8
|
7.3 ± 1.8
|
0.05
|
|
BUN (mg/dL)
|
35.2 ± 12.7
|
36.1 ± 12.7
|
0.37
|
|
Serum creatinine (mg/dL)
|
2.5 ± 0.8
|
2.6 ± 0.9
|
0.06
|
|
eGFR by Creatinine (mL/min/1.73m2)
|
31.7 ± 11.3
|
32.0 ± 13.1
|
0.57
|
|
Serum albumin (g/dL)
|
3.9 ± 0.6
|
3.9 ± 0.5
|
0.43
|
- The paired t-tests were performed to compare the two groups
- Abbreviation: OSCA oral spherical carbon adsorbent, BMI body mass index, BP blood pressure, CKD chronic kidney disease, eGFR estimated glomerular filtration rate
